menu search

Tiziana life sciences stock continues to climb; coo ‘excited' by recent results

Tiziana Life Sciences Ltd (NASDAQ:TLSA) shares rose 8% to $0.86 in midday trading on Monday after the clinical...

October 16, 2023, 1:15 pm

Immix biopharma completes 3rd nxc-201 engineering batch at its u.s. car-t manufacturing site

Successful completion supports expansion of its ongoing NEXICART-1 (NCT04720313) NXC-201 CAR-T clinical...

October 16, 2023, 1:05 pm

Prothena shares buoyed by sale rumors

Shares of Prothena Corporation (NASDAQ:PRTA) added almost 25% on rumours the biotechnology firm is exploring a sale ahead of the release of key data f...

October 16, 2023, 12:09 pm

Terns pharmaceuticals announces global phase 1 clinical trial design of tern-701 for the treatment of chronic myeloid leukemia

Investigational New Drug application cleared by U.S. Food and Drug Administration Design leverages insights from partner’s ongoing Phase 1 trial in ...

October 16, 2023, 12:05 pm

Clearside biomedical positive oasis and extension study data presented at the retina society 56th annual scientific meeting

– Excellent Safety Profile, Stable Vision, and Reduced Frequency of Injections Observed for up to 6 months – – ODYSSEY Phase 2b ...

October 16, 2023, 11:05 am

Olema oncology announces phase 2 monotherapy clinical results to be presented at the 2023 esmo congress

Oral presentation by Dr. Nancy U. Lin from Dana-Farber Cancer Institute at 8:55 a.m. CEST/2:55 a.m. ET on October 22, 2023Olema will host an investor ...

October 16, 2023, 11:02 am

Lyra therapeutics announces appointment of ronan o’brien as chief legal officer

WATERTOWN, Mass., Oct. 16, 2023 (GLOBE NEWSWIRE) — Lyra Therapeutics, Inc. (Nasdaq: LYRA) (“Lyra” or the “Company”), a ...

October 16, 2023, 11:00 am

Omega therapeutics presents new preclinical data supporting the potential of otx-2101 in combination settings for treatment of nsclc

Combination of a MYC-targeting epigenomic controller with immune checkpoint or EGFR inhibitor enhanced anti-tumor activity in models of NSCLC CAMBRIDG...

October 16, 2023, 11:00 am

Inhibikase therapeutics highlights unblinded functional analysis from the 201 trial of risvodetinib in untreated parkinson’s disease and provides update on ongoing enrollment

BOSTON and ATLANTA, Oct. 16, 2023 (GLOBE NEWSWIRE) — Inhibikase Therapeutics, Inc. (Nasdaq: IKT) (Inhibikase or Company), a ...

October 16, 2023, 11:00 am

Nanoviricides updates investors on phase 1a/1b trial of antiviral drug candidate for coronavirus

NanoViricides (NYSE-A:NNVC) said it has sufficient funds to complete its ongoing Phase 1a/1b clinical t...

October 16, 2023, 9:13 am

Spectral ai expands diabetic foot ulcer study to additional clinical sites

Spectral AI Inc (NASDAQ:MDAI) announced it has added seven clinical sites to its multi-centre study of ...

October 16, 2023, 8:45 am

Tiziana life sciences reveals positive clinical results for ms patients treated with foralumab

Tiziana Life Sciences Ltd (NASDAQ:TLSA) has announced six-month data showing positive clinical improvem...

October 16, 2023, 8:28 am

Why is contrafect (cfrx) stock up 23% today?

ContraFect (NASDAQ: CFRX ) stock is rising higher on Monday as investors react to an update from the Food and Drug Administration (FDA). The FDA has ...

October 16, 2023, 8:19 am

Kiora pharmaceuticals to participate in the lytham partners fall 2023 investor conference

Encinitas, California--(Newsfile Corp. - October 16, 2023) - Kiora Pharmaceuticals (NASDAQ: KPRX) invites investors to view the Company's online prese...

October 16, 2023, 7:00 am

Biontech to present multiple program updates across modalities at esmo congress 2023

MAINZ, Germany, October 16, 2023 – BioNTech SE (Nasdaq: BNTX, “BioNTech” or “the Company”) will present data across its oncology pipeline, c...

October 16, 2023, 3:30 am

Arvinas announces upcoming bavdegalutamide poster presentation at esmo congress 2023

NEW HAVEN, Conn., Oct. 15, 2023 (GLOBE NEWSWIRE) — Arvinas, Inc. (Nasdaq: ARVN), a clinical-stage bio...

October 15, 2023, 10:07 pm

Precede biosciences announces first scientific data from its liquid biopsy platform to be presented as an oral presentation at esmo 2023

Data from more than 400 patients across 15 cancers demonstrate the significance of the Precede approach to informing therapeutic decision making and <...

October 15, 2023, 10:05 pm

Merus announces business update conference call

UTRECHT, The Netherlands and CAMBRIDGE, Mass., Oct. 15, 2023 (GLOBE NEWSWIRE) -- Merus N.V. (Nasdaq: MRUS) (Merus, the Company, we, or our), a ...

October 15, 2023, 7:58 pm

Carmot therapeutics highlights clinical data from its pipeline of treatments for obesity and diabetes at obesityweek®

– CT-388 administered once-weekly resulted in clinically meaningful weight loss and insulin sensitivi...

October 15, 2023, 4:00 pm

Coherus announces toripalimab data at 2023 aacr-nci-eortc international conference on molecular targets and cancer therapeutics

— Data demonstrate preclinical potent T cell activation and differentiated mechanism of action and en...

October 14, 2023, 4:30 pm


Search within

Pages Search Results: